Drug Pricing Insights: Express Scripts Challenges FTC Report on Pharmaceuticals Policy
Tuesday, 17 September 2024, 05:19
Drug Pricing and Pharmaceuticals Policy at Stake
In a bold move, Express Scripts, one of the largest pharmacy benefit managers in the U.S., has filed a lawsuit against the Federal Trade Commission (FTC). The lawsuit seeks to vacate a recent report that Express Scripts claims is 'biased' against the practices of pharmacy benefit managers. This development is essential as it highlights the ongoing tensions surrounding drug pricing and pharmaceuticals policy.
Implications for the Industry
- This lawsuit could reshape discussions about drug pricing.
- Pharmaceutical companies may need to rethink their pricing strategies.
- The outcome may set a precedent for how similar reports are perceived in the future.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.